With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the University of Michigan, and Daneen Seekoni, Vice President of Policy and Advocacy ...
This shift could improve care coordination and create opportunities for cost savings through enhanced formulary flexibility ...
That’s why we need Senate Bill 41, authored by Sen. Scott Wiener, D-San Francisco, which will require a more fair and ...
Clayton Irvine, PharmD, MBA, MS, emphasized that optimizing value-based access to cell and gene therapies requires standardized care protocols, coordinated transitions between care settings, careful ...
Consumers have one major defense against rising costs, shrinking provider networks and disappearing benefits: Medicare’s fall ...
From prior authorization hurdles to quantity caps, insurance restrictions on antiemetics are common and inconsistent across plans, drugs, and states, new data show.
Opinion
7monon MSNOpinion
Trump is fighting Biden’s drug-price battle — but patients will pay the cost
The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat for former President Joe Biden and his signature legislative accomplishment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback